摘要
目的了解南京地区24家医院降糖药的临床使用情况和变化趋势。方法比较2002～2003年药品购入数据,采用MicrosoftExcel进行统计和分析。结果磺酰脲类和双胍类药仍然是临床主要使用的降糖药,占所有降糖药使用DDDs总值的70%左右,糖苷酶抑制剂和胰岛素在临床也有较广泛的使用,占所有降糖药使用DDDs总值的20%以上,其他新型降糖药和中成药的使用只占DDDs总值的10%以下。二甲双胍、格列齐特、阿卡波糖、格列吡嗪、胰岛素为临床一线用药。结论南京地区降糖药的使用结构比较合理。费用是糖尿病患者能否规范、连续用药的一个重要的影响因素。
Objective: To survey and evaluate the situation of present clinic usage of antihyperglycemic drugs, estimate the consuming trend of antihyperglycemic drugs, and discuss the rational methods in applying antihyperglycemic drugs.Method: The drugs purchasing data during year 2002 to 2003 in hospitals was compared, the data were analy by Microsoft Excel.Result: Sulfonylureas and bigunides which accounted for 70 percent in total antihyperglycemic DDDS, were most commonly used. Insulin and α glycosidase inhibitors were used also accounting for 20 percent in total DDDs. Some other new drugs and traditional Chinese medicine used were less than 10 percent in total DDDs. The first line of antihyperglycemic drugs included metformin, gliclazide, acarbose, glipizide, and insulin.Conclusion: Clinical usage of antigyperglycemic drugs is relatively reasonable in Nanjing district. The cost of diabetics is a main factor which will influence the antihyperglycemic drugs used normatively and continuously.
出处
《中国药师》
CAS
2004年第10期801-802,共2页
China Pharmacist
